Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1998 Aug;51(8):588–592. doi: 10.1136/jcp.51.8.588

Differential expression of the cancer associated antigens T (Thomsen-Friedenreich) and Tn to the skin in primary and metastatic carcinomas.

J Kanitakis 1, I al-Rifai 1, M Faure 1, A Claudy 1
PMCID: PMC500850  PMID: 9828816

Abstract

AIM: To study the immunohistochemical expression of the Thomsen-Friedenreich antigen (T) and its precursor, Tn, in the skin in various cancers. METHODS: T and Tn antigens were studied with monoclonal antibodies in 91 primary premalignant and malignant lesions, 13 cases of Paget's disease, and 26 carcinomas metastatic to the skin. The material had been collected over a 10 year period, formalin fixed, and paraffin embedded. Diagnoses had been made after examination of standard histological sections, supplemented when needed by appropriate immunohistochemical staining. RESULTS: 21% and 29% of the primary cutaneous premalignant and malignant epithelial tumours expressed the Tn and T antigens, respectively. By contrast, 81% of metastatic carcinomas to the skin were Tn positive, while only 23% of them expressed the T antigen. All cases of Paget's disease were Tn positive but only 15% of them expressed the T antigen. The 21 nonepithelial tumours (including melanomas) were as a rule unreactive. CONCLUSIONS: The accumulation of the precursor (Tn) antigen in tumours metastasising to the skin highlights the incomplete glycosylation of carbohydrate antigens occurring in these tumours. The predominant Tn versus T antigen expression appears to be a useful immunohistochemical feature which may aid in the differentiation of primary cutaneous carcinomas from metastatic tumours.

Full text

PDF
588

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barr N., Taylor C. R., Young T., Springer G. F. Are pancarcinoma T and Tn differentiation antigens? Cancer. 1989 Aug 15;64(4):834–841. doi: 10.1002/1097-0142(19890815)64:4<834::aid-cncr2820640413>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  2. Blasco E., Torrado J., Belloso L., Arocena F., Gutierrez-Hoyos A., Cuadrado E. T-antigen. A prognostic indicator of high recurrence index in transitional carcinoma of the bladder. Cancer. 1988 Mar 15;61(6):1091–1095. doi: 10.1002/1097-0142(19880315)61:6<1091::aid-cncr2820610607>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  3. Campbell B. J., Finnie I. A., Hounsell E. F., Rhodes J. M. Direct demonstration of increased expression of Thomsen-Friedenreich (TF) antigen in colonic adenocarcinoma and ulcerative colitis mucin and its concealment in normal mucin. J Clin Invest. 1995 Feb;95(2):571–576. doi: 10.1172/JCI117700. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cao Y., Stosiek P., Springer G. F., Karsten U. Thomsen-Friedenreich-related carbohydrate antigens in normal adult human tissues: a systematic and comparative study. Histochem Cell Biol. 1996 Aug;106(2):197–207. doi: 10.1007/BF02484401. [DOI] [PubMed] [Google Scholar]
  5. Chung Y. S., Yamashita Y., Kato Y., Nakata B., Sawada T., Sowa M. Prognostic significance of T antigen expression in patients with gastric carcinoma. Cancer. 1996 May 1;77(9):1768–1773. doi: 10.1002/(SICI)1097-0142(19960501)77:9<1768::AID-CNCR2>3.0.CO;2-8. [DOI] [PubMed] [Google Scholar]
  6. Dall'olio F. Protein glycosylation in cancer biology: an overview. Clin Mol Pathol. 1996 Jun;49(3):M126–M135. doi: 10.1136/mp.49.3.m126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gessner P., Riedl S., Quentmaier A., Kemmner W. Enhanced activity of CMP-neuAc:Gal beta 1-4GlcNAc:alpha 2,6-sialyltransferase in metastasizing human colorectal tumor tissue and serum of tumor patients. Cancer Lett. 1993 Dec 20;75(3):143–149. doi: 10.1016/0304-3835(93)90056-f. [DOI] [PubMed] [Google Scholar]
  8. Ghazizadeh M., Oguro T., Sasaki Y., Aihara K., Araki T., Springer G. F. Immunohistochemical and ultrastructural localization of T antigen in ovarian tumors. Am J Clin Pathol. 1990 Mar;93(3):315–321. doi: 10.1093/ajcp/93.3.315. [DOI] [PubMed] [Google Scholar]
  9. Hamada S., Furumoto H., Kamada M., Hirao T., Aono T. High expression rate of Tn antigen in metastatic lesions of uterine cervical cancers. Cancer Lett. 1993 Nov 1;74(3):167–173. doi: 10.1016/0304-3835(93)90239-6. [DOI] [PubMed] [Google Scholar]
  10. Hanisch F. G., Baldus S. E. The Thomsen-Friedenreich (TF) antigen: a critical review on the structural, biosynthetic and histochemical aspects of a pancarcinoma-associated antigen. Histol Histopathol. 1997 Jan;12(1):263–281. [PubMed] [Google Scholar]
  11. Hirao T., Sakamoto Y., Kamada M., Hamada S., Aono T. Tn antigen, a marker of potential for metastasis of uterine cervix cancer cells. Cancer. 1993 Jul 1;72(1):154–159. doi: 10.1002/1097-0142(19930701)72:1<154::aid-cncr2820720129>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  12. Itzkowitz S. H., Yuan M., Montgomery C. K., Kjeldsen T., Takahashi H. K., Bigbee W. L., Kim Y. S. Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer. Cancer Res. 1989 Jan 1;49(1):197–204. [PubMed] [Google Scholar]
  13. Kanitakis J., Al-Rifai I., Faure M., Claudy A. Demodex mites of human skin express Tn but not T (Thomsen-Friedenreich) antigen immunoreactivity. J Cutan Pathol. 1997 Aug;24(7):454–455. doi: 10.1111/j.1600-0560.1997.tb00823.x. [DOI] [PubMed] [Google Scholar]
  14. Kanitakis J., Roche P., Thivolet J. The expression of PNA-lectin binding sites and S-100 protein in histiocytic lesions of the skin. A comparative immunohistochemical study. Acta Derm Venereol. 1988;68(1):1–7. [PubMed] [Google Scholar]
  15. Kanitakis J., al-Rifai I., Faure M., Claudy A. Thomsen-Friedenreich and its precursor (Tn) antigen expression in normal skin and in benign cutaneous tumours: a marker for sebaceous differentiation. Acta Derm Venereol. 1998 May;78(3):173–176. doi: 10.1080/000155598441468. [DOI] [PubMed] [Google Scholar]
  16. Kannon G., Park H. K. Utility of peanut agglutinin (PNA) in the diagnosis of squamous cell carcinoma and keratoacanthoma. Am J Dermatopathol. 1990 Feb;12(1):31–36. doi: 10.1097/00000372-199002000-00005. [DOI] [PubMed] [Google Scholar]
  17. Langkilde N. C. T-antigens in primary non-invasive and superficially invasive human urinary bladder tumors: the correlation to tumor recurrence and tumor progression. A mini-review. Scand J Urol Nephrol Suppl. 1995;172:45–49. [PubMed] [Google Scholar]
  18. Longenecker B. M., Willans D. J., MacLean G. D., Selvaraj S., Suresh M. R., Noujaim A. A. Monoclonal antibodies and synthetic tumor-associated glycoconjugates in the study of the expression of Thomsen-Friedenreich-like and Tn-like antigens on human cancers. J Natl Cancer Inst. 1987 Mar;78(3):489–496. [PubMed] [Google Scholar]
  19. Orntoft T. F., Harving N., Langkilde N. C. O-linked mucin-type glycoproteins in normal and malignant colon mucosa: lack of T-antigen expression and accumulation of Tn and sialosyl-Tn antigens in carcinomas. Int J Cancer. 1990 Apr 15;45(4):666–672. doi: 10.1002/ijc.2910450416. [DOI] [PubMed] [Google Scholar]
  20. Reano A., Faure M., Jacques Y., Reichert U., Schaefer H., Thivolet J. Lectins as markers of human epidermal cell differentiation. Differentiation. 1982;22(3):205–210. doi: 10.1111/j.1432-0436.1982.tb01252.x. [DOI] [PubMed] [Google Scholar]
  21. Schuessler M. H., Pintado S., Welt S., Real F. X., Xu M., Melamed M. R., Lloyd K. O., Oettgen H. F. Blood group and blood-group-related antigens in normal pancreas and pancreas cancer: enhanced expression of precursor type 1, Tn and sialyl-Tn in pancreas cancer. Int J Cancer. 1991 Jan 21;47(2):180–187. doi: 10.1002/ijc.2910470204. [DOI] [PubMed] [Google Scholar]
  22. Sell S. Cancer-associated carbohydrates identified by monoclonal antibodies. Hum Pathol. 1990 Oct;21(10):1003–1019. doi: 10.1016/0046-8177(90)90250-9. [DOI] [PubMed] [Google Scholar]
  23. Sharma V., Vijayan M., Surolia A. Imparting exquisite specificity to peanut agglutinin for the tumor-associated Thomsen-Friedenreich antigen by redesign of its combining site. J Biol Chem. 1996 Aug 30;271(35):21209–21213. doi: 10.1074/jbc.271.35.21209. [DOI] [PubMed] [Google Scholar]
  24. Springer G. F., Desai P. R., Banatwala I. Blood group MN antigens and precursors in normal and malignant human breast glandular tissue. J Natl Cancer Inst. 1975 Feb;54(2):335–339. [PubMed] [Google Scholar]
  25. Springer G. F., Desai P. R., Ghazizadeh M., Tegtmeyer H. T/Tn pancarcinoma autoantigens: fundamental, diagnostic, and prognostic aspects. Cancer Detect Prev. 1995;19(2):173–182. [PubMed] [Google Scholar]
  26. Springer G. F., Desai P. R., Wise W., Carlstedt S. C., Tegtmeyer H., Stein R., Scanlon E. F. Pancarcinoma T and Tn epitopes: autoimmunogens and diagnostic markers that reveal incipient carcinomas and help establish prognosis. Immunol Ser. 1990;53:587–612. [PubMed] [Google Scholar]
  27. Springer G. F. Tn epitope (N-acetyl-D-galactosamine alpha-O-serine/threonine) density in primary breast carcinoma: a functional predictor of aggressiveness. Mol Immunol. 1989 Jan;26(1):1–5. doi: 10.1016/0161-5890(89)90013-8. [DOI] [PubMed] [Google Scholar]
  28. Tsubura A., Fujita Y., Sasaki M., Morii S. Lectin-binding profiles for normal skin appendages and their tumors. J Cutan Pathol. 1992 Dec;19(6):483–489. doi: 10.1111/j.1600-0560.1992.tb01601.x. [DOI] [PubMed] [Google Scholar]
  29. Vigneswaran N., Haneke E., Peters K. P. Peanut agglutinin immunohistochemistry of basal cell carcinoma. J Cutan Pathol. 1987 Jun;14(3):147–153. doi: 10.1111/j.1600-0560.1987.tb00489.x. [DOI] [PubMed] [Google Scholar]
  30. Zebda N., Bailly M., Brown S., Doré J. F., Berthier-Vergnes O. Expression of PNA-binding sites on specific glycoproteins by human melanoma cells is associated with a high metastatic potential. J Cell Biochem. 1994 Feb;54(2):161–173. doi: 10.1002/jcb.240540205. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES